about
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm.The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancerTamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM StudyPrognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast CancerUnexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast CancerTumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapyIdentification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations
P50
Q38510960-7A28FE21-F46C-47F3-B769-F197A919A35DQ38909264-A50F45A7-3E9F-4D30-91DD-2619DFFACFE9Q39226891-066BF2EF-6567-4B9B-BCC1-C1AAC352851DQ40137431-4F3C89B9-B13F-4F11-A77D-3A23F81F3B6BQ60683163-C8884807-183B-4A72-BD13-BD041602FB60Q91196001-01F12808-C4C2-44D2-A0C3-99E4137B8AF1Q91254019-FDA1B2E2-7752-448E-BC46-14A063BF627FQ91310014-0DDA8E05-D3D8-45C0-84E2-6A3C536403CFQ92149082-F953074D-AC0A-4DD4-8C55-5BCE3D3CD406Q93230171-0D9E51D0-4CCC-4420-9E9E-4B0246203F47
P50
description
researcher ORCID ID = 0000-0001-7618-6313
@en
wetenschapper
@nl
name
Lynn Jongen
@ast
Lynn Jongen
@en
Lynn Jongen
@es
Lynn Jongen
@nl
type
label
Lynn Jongen
@ast
Lynn Jongen
@en
Lynn Jongen
@es
Lynn Jongen
@nl
prefLabel
Lynn Jongen
@ast
Lynn Jongen
@en
Lynn Jongen
@es
Lynn Jongen
@nl
P106
P31
P496
0000-0001-7618-6313